BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Pramipexole

A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME.

297+ PubMed studies analyzed · 66 RCTs · Evidence Score: 56

Research Domains

Pramipexole has been studied across 18 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, 🧠 Neuroprotection, 😴 Sleep, 🧘 Stress & Anxiety. The primary research focus is 🌤️ Mood & Depression with 66% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Pramipexole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Amisulpride
9 shared targets
paliperidone
10 shared targets
Cabergoline
12 shared targets
l
9 shared targets
fananserin
10 shared targets
silodosin
9 shared targets
clozapine
13 shared targets
risperidone
12 shared targets
nantenine
10 shared targets
latrepirdine
10 shared targets
Loading evidence profile...

This evidence profile for Pramipexole is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.